Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Census population 3,979,576. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Los Angeles clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Los Angeles storefront.
Umbilical Cord Tissue Allograft in Los Angeles, CA for clinics & physicians. HCT/P 361 compliant umbilical… Compliance support & pricing — contact Hawk Medical.
13.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Population 3,979,576. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JE documentation are ready before the first application of umbilical cord tissue allograft.
National Umbilical Cord Tissue Allograft notes (how the product actually works)13.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 3,979,576 residents will still mix those payers. CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Los Angeles trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 27.3%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Los Angeles trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Noridian Healthcare Solutions CTP articles. Mixing those codes is a billing error.
California is in CMS MAC JE, administered by Noridian Healthcare Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 11.9% diabetes and 18.8% arthritis for Los Angeles — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Los Angeles, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Los Angeles is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Los Angeles — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Los Angeles. Useful for joint-program math; still needs a diagnosis and privileging.
No Los Angeles storefront. Joe Bradley is an active practice owner. umbilical cord tissue allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.